10-Q
Quarterly Report
AIM IMMUNOTECH INC.
AIM
NYSEAMER
CIK: 946644
File #: 001-27072
Balance Sheet
38 line items · 2 periods
XBRL
| Item | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 2,347,000 | 1,701,000 |
Cash and Cash Equivalents | 62,000 | 2,276,000 |
Fair Value, Recurring | 62,000 | 2,276,000 |
Fair Value, Inputs, Level 1 - Fair Value, Recurring | 62,000 | 2,276,000 |
Other Non-Operating Current Assets | 166,000 | 199,000 |
Total current assets | 2,575,000 | 4,176,000 |
Property, Plant and Equipment | 80,000 | 108,000 |
Operating Lease Right-of-Use Asset | 436,000 | 618,000 |
Intangible Assets | 2,041,000 | 2,594,000 |
Patents | 1,955,000 | 2,495,000 |
Trademarks | 86,000 | 99,000 |
Other Non-Operating Non-Current Assets | 362,000 | 1,112,000 |
Total assets | 5,494,000 | 8,608,000 |
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current liabilities: | ||
Accounts Payable | 1,252,000 | 6,383,000 |
Other Current Liabilities | 679,000 | 606,000 |
Operating Lease Liability, Current | 232,000 | 239,000 |
Short-Term Debt | 1,880,000 | 2,307,000 |
Total current liabilities | 4,043,000 | 9,535,000 |
Long-term liabilities: | ||
Operating Lease Liability, Non-Current | 226,000 | 395,000 |
Other Non-Operating Non-Current Liabilities | 7,302,000 | — |
Fair Value, Recurring | 7,302,000 | — |
Fair Value, Inputs, Level 3 - Fair Value, Recurring | 7,302,000 | — |
Total liabilities | 11,571,000 | 9,930,000 |
Stockholders’ deficit: | ||
Total Stockholders' Equity | 3,000 | 1,000 |
Total Stockholders' Equity | 430,531,000 | 425,505,000 |
Total Stockholders' Equity | (436,611,000) | (426,828,000) |
Total stockholders’ equity | (6,077,000) | (1,322,000) |
Common Stock | 3,000 | 1,000 |
Additional Paid-in Capital | 430,531,000 | 425,505,000 |
Retained Earnings | (436,611,000) | (426,828,000) |
Minimum | 6,000,000 | — |
Total liabilities and stockholders’ equity | 5,494,000 | 8,608,000 |